Brent Douty,Andrew W. Buesking,David M. Burns,Andrew P. Combs,Nikoo Falahatpisheh,Ravi Kumar Jalluri,Daniel Levy,Padmaja Polam,Lixin Shao,Stacey Shepard,Artem Shvartsbart,Richard B. Sparks,Eddy W. Yue
申请号：
US16163341
公开号：
US10738057B2
申请日:
2018.10.17
申请国别(地区):
US
年份:
2020
代理人:
摘要：
This application relates to compounds of Formula (I):or pharmaceutically acceptable salts thereof, which are inhibitors of PI3K-γ which are useful for the treatment of disorders such as autoimmune diseases, cancer, cardiovascular diseases, and neurodegenerative diseases.
